Catalyst Wire Dossier Catalyst Wire Dossier

Atripla

efavirenz/emtricitabine/tenofovir disoproxil fumarate · Bristol-Myers Squibb; Gilead Sciences
Drug timelines are a Plus or Pro feature.

24 regulatory and trial events tracked for Atripla, covering 2010-12-17 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults With HIV-1 [Phase 4]

See pricing